Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?

L. M. Soveri, Kethe Hermunen, A. de Gramont, T. Poussa, E. Quinaux, P. Bono, T. Andre, P. Osterlund

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Journal of Cancer
Volume50
Issue number17
Pages (from-to)2966-2974
Number of pages9
ISSN0959-8049
DOIs
Publication statusPublished - Nov 2014
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 5-Fluorouracil
  • Adverse events
  • Prognosis
  • Colorectal cancer
  • Adjuvant therapy
  • III COLON-CANCER
  • STAGE-II
  • RANDOMIZED-TRIAL
  • CHEMOTHERAPY EFFICACY
  • DOSE ADJUSTMENT
  • BREAST-CANCER
  • FLUOROURACIL
  • CAPECITABINE
  • OXALIPLATIN
  • THERAPY
  • 3122 Cancers

Cite this